Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of ...
The Philips HeartStart OnSite Defibrillator is designed to be the easiest-to-use, and most reliable defibrillator available. Available without a prescription from ActiveForever.com, the Philips ...
Philips receives FDA premarket approval for its HeartStart OnSite and HeartStart Home defibrillators
Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug ...
The FDA has issued a safety communication indicating that certain HeartStart automated external defibrillators may not function properly in a cardiac emergency. Approximately 700,000 HeartStart FRx, ...
Philips HeartStart OnSite AEDs help allow anyone with little or no training to treat the most common cause of suspected sudden cardiac arrest (SCA) by delivering a shock quickly and effectively, ...
WASHINGTON – Federal health regulators are warning the public that certain cardiac defibrillators recalled by Philips Healthcare may fail to deliver a needed shock in an emergency. Defibrillators are ...
There’s many a heart-wrenching tale of people even the athletic and physically fit ones who suddenly collapse. This is what’s called sudden cardiac arrest (SCA), which comes like the proverbial ...
Amsterdam, the Netherlands and Cambridge, MA - Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback